Table 2. Analysis of GS in relation to of the ECM markers Detected.
Variable | Category of Expression | Average | EP | 95% CI | Log-rank χ2 | Log-rank p-value | |
---|---|---|---|---|---|---|---|
Lower | Upper | ||||||
ITGB5 | Hypo | 37.4 | 2.0 | 33.4 | 41.4 | 3.106 | 0.078 |
Hyper | 43.1 | 1.8 | 39.5 | 46.7 | |||
ITGAV | Hypo | 44.5 | 1.6 | 41.4 | 47.5 | 11.396 | 0.001 |
Hyper | 34.8 | 2.3 | 30.2 | 39.3 | |||
ITGA3 | Hypo | 44.5 | 1.7 | 41.2 | 47.7 | 9.477 | 0.002 |
Hyper | 35.6 | 2.2 | 31.4 | 39.8 | |||
ITGA5 | Hypo | 42.8 | 1.8 | 39.3 | 46.3 | 2.484 | 0.115 |
Hyper | 37.4 | 2.1 | 33.3 | 41.5 | |||
ITGA6 | Hypo | 44.6 | 1.5 | 41.7 | 47.6 | 10.845 | 0.001 |
Hyper | 34.1 | 2.3 | 29.7 | 38.6 | |||
Fibronectin | Hypo | 40.3 | 1.5 | 37.3 | 43.3 | 0.147 | 0.701 |
Hyper | 38.5 | 3.1 | 32.5 | 44.6 | |||
SPARC | Hypo | 28.7 | 5.3 | 18.2 | 39.2 | 4.419 | 0.036 |
Hyper | 41.0 | 1.5 | 38.1 | 43.8 | |||
SPP1 | Hypo | 37.3 | 4.4 | 28.7 | 45.9 | 0.036 | 0.849 |
Hyper | 40.4 | 1.5 | 37.4 | 43.4 | |||
VCAM | Hypo | 36.3 | 2.7 | 31.0 | 41.5 | 3.203 | 0.073 |
Hyper | 41.9 | 1.6 | 38.7 | 45.2 | |||
MMP1 | Hypo | 41.5 | 1.6 | 38.4 | 44.6 | 2.773 | 0.096 |
Hyper | 35.1 | 3.2 | 28.9 | 41.3 | |||
MMP2 | Hypo | 42.8 | 1.8 | 39.3 | 46.3 | 2.484 | 0.115 |
Hyper | 37.4 | 2.1 | 33.3 | 41.5 | |||
MMP9 | Hypo | 43.0 | 1.8 | 39.5 | 46.5 | 4.507 | 0.034 |
Hyper | 36.8 | 2.2 | 32.6 | 41.0 | |||
MMP11 | Hypo | 41.3 | 2.3 | 36.8 | 45.9 | 0.365 | 0.546 |
Hyper | 39.0 | 1.8 | 35.5 | 42.5 | |||
MMP16 | Hypo | 42.9 | 1.8 | 39.4 | 46.3 | 4.292 | 0.038 |
Hyper | 36.6 | 2.2 | 32.2 | 41.0 | |||
COL6A2 | Hypo | 36.6 | 2.6 | 31.4 | 41.7 | 2.806 | 0.094 |
Hyper | 41.8 | 1.7 | 38.6 | 45.1 |
GS: global survival.; EP: equal-precision confidence bands.; CI: confidence interval.